In this prospective pilot study without control group children and young adults (10-25 years old) diagnosed with Bardet-Biedl syndrome and treated with Metformin for their adipositas will be evaluated for a possible additional effect of Metformin on visual acuity.
Within experiments with animals a positive effect of Metformin concerning the photo receptors was shown. Several patients of the university hospital Tübingen with Bardet-Biedl-Syndrome and Metformin therapy due to their adipositas reported a subjective improvement of the visual acuity which was confirmed by opthalmologic tests. This will be checked in a prospective pilot study without control group including children and young adults (10-25 years old) diagnosed with Bardet-Biedl syndrome and treated with Metformin for their adipositas. Therefore a possible additional effect of Metformin on visual acuity will be evaluated under controlled conditions.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
500, 850 or 1000 mg depending on body weight once daily for 24 weeks
Visual acuity
Course of visual acuity according to appropriate table
Time frame: Baseline to day 210
Number of letters read
Course visual acuity defined as number of letters read
Time frame: Baseline to day 210
Results of Static perimetry
Course of results of static perimetry given by measurement of light contrast sensitivity within at least 5 central points.
Time frame: Baseline to day 210
Results of Kinetic perimetry
Course of results of kinetic perimetry given by mapping the visual field sensitivity boundaries using Goldmann perimetry
Time frame: Baseline to day 210
Electroretinogram (ERG) dim-flash
Course of values of ERG dim-flash
Time frame: Baseline to day 210
Electroretinogram (ERG) standard flash
Course of values of ERG standard flash at 3 ods/m2
Time frame: Baseline to day 210
Electroretinogram (ERG) cone-single-flash
Course of values of ERG cone-single-flash at 30cd/m2
Time frame: Baseline to day 210
Electroretinogram (ERG) 30-Hz-Flicker
Course of values of ERG measured by 30-Hz-Flicker in all patients
Time frame: Baseline to day 210
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Visual evoked potential (VEP) - amplitude
Course of results of measurement of VEP amplitude
Time frame: Baseline to day 210
Visual evoked potential (VEP) - latency time
Course of results of measurement of VEP latency time
Time frame: Baseline to day 210
FST
Full-Field-Stimulus Threshold
Time frame: Baseline to day 210
optical coherence tomography (OCT)
Course of central thickness of retina measured by OCT
Time frame: Baseline to day 210